Takeda Pharmaceutical Company Limited ( TAK) - Key Metrics
TAK Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | $386.06 | $35.82 | $40.39 | $23.36 |
| 2025Q4 | $356.69 | -$7.93 | $23.85 | $3.24 |
| 2025Q3 | $384.03 | $33.40 | $118.15 | $47.76 |
| 2025Q2 | $352.72 | -$3.74 | $119.88 | $103.14 |
| 2025Q1 | $353.63 | $39.70 | $68.84 | $44.85 |
TAK Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | 132.63% | 18.18 |
| 2025Q4 | -35.48% | -92.72 |
| 2025Q3 | 141.25% | 18.31 |
| 2025Q2 | -74.45% | -144.64 |
| 2025Q1 | 116.94% | 14.02 |
TAK Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q1 | 0.90% | 1.82% |
| 2025Q4 | 0.11% | 0.10% |
| 2025Q3 | 1.95% | 1.93% |
| 2025Q2 | 4.77% | 0.13% |
| 2025Q1 | 2.01% | 2.09% |
TAK
Price: $17.82
Dividend Yield: 3.42%
Forward Dividend Yield: 3.45%
Payout Ratio: 177.09%
Dividend Per Share: 0.62 USD
Earnings Per Share: -0.33 USD
Exchange: NYQ
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Country: Japan
Volume: 2.3 million
Market Capitalization: 58.7 billion
Average Dividend Frequency: 2
Years Paying Dividends: 19
DGR3: -2.55%
DGR5: -3.99%
DGR10: -5.34%